File Download
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: Beneficial vascular effect of a non-selective PPAR activator in aorta of spontaneously hypertensive rats
Title | Beneficial vascular effect of a non-selective PPAR activator in aorta of spontaneously hypertensive rats |
---|---|
Authors | |
Keywords | Biology |
Issue Date | 2010 |
Publisher | Federation of American Societies for Experimental Biology. The Journal's web site is located at http://www.fasebj.org/ |
Citation | The 2010 ASIP Annual Meeting at Experimental Biology (EB 2010), Anaheim, CA., 24-28 April 2010. In The FASEB Journal, 2010, v. 24 meeting abstracts, abstract no. 955.10 How to Cite? |
Abstract | Wy14643 is a potent activator of peroxisome proliferator-activated receptor (PPAR)alpha and gamma. The present study aimed to determine whether or not Wy14643 improved endothelial dysfunction in hypertension, and if so, the mechanism involved. Isometric tension in isolated thoracic aortic rings of spontaneously hypertensive rats was recorded. Wy14643 caused greater relaxations than fenofibrate (PPAR alpha activator) or rosiglitazone (PPAR gamma activator). L-NAME (nitric oxide synthase inhibitor) and ODQ (soluble guanylyl cyclase inhibitor) alone and in combination inhibited these relaxations to the same extent. Compound C (AMP-activated protein kinase (AMPK) inhibitor) reduced Wy14643-induced relaxations to the same extent as L-NAME. Endothelium-dependent contractions evoked by acetylcholine in the presence of L-NAME were reduced by Wy14643, fenofibrate but not rosiglitazone. Moreover, Wy14643 and fenofibrate inhibited acetylcholine-induced prostanoids release to the same extent. Our data suggests that the three PPAR activators induce nitric oxide-mediated relaxation through activation of AMPK. This relaxing effect is more prominent with Wy14643. Together with the ability to reduce the release of endothelium-dependent contracting factor, it appears that Wy14643 produces better protection against vascular diseases in spontaneous hypertension. |
Description | Open Access Journal |
Persistent Identifier | http://hdl.handle.net/10722/126876 |
ISSN | 2021 Impact Factor: 5.834 2020 SCImago Journal Rankings: 1.709 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Qu, C | en_HK |
dc.contributor.author | Leung, SWS | en_HK |
dc.contributor.author | Vanhoutte, PM | en_HK |
dc.contributor.author | Man, RYK | en_HK |
dc.date.accessioned | 2010-10-31T12:53:44Z | - |
dc.date.available | 2010-10-31T12:53:44Z | - |
dc.date.issued | 2010 | en_HK |
dc.identifier.citation | The 2010 ASIP Annual Meeting at Experimental Biology (EB 2010), Anaheim, CA., 24-28 April 2010. In The FASEB Journal, 2010, v. 24 meeting abstracts, abstract no. 955.10 | en_HK |
dc.identifier.issn | 0892-6638 | - |
dc.identifier.uri | http://hdl.handle.net/10722/126876 | - |
dc.description | Open Access Journal | - |
dc.description.abstract | Wy14643 is a potent activator of peroxisome proliferator-activated receptor (PPAR)alpha and gamma. The present study aimed to determine whether or not Wy14643 improved endothelial dysfunction in hypertension, and if so, the mechanism involved. Isometric tension in isolated thoracic aortic rings of spontaneously hypertensive rats was recorded. Wy14643 caused greater relaxations than fenofibrate (PPAR alpha activator) or rosiglitazone (PPAR gamma activator). L-NAME (nitric oxide synthase inhibitor) and ODQ (soluble guanylyl cyclase inhibitor) alone and in combination inhibited these relaxations to the same extent. Compound C (AMP-activated protein kinase (AMPK) inhibitor) reduced Wy14643-induced relaxations to the same extent as L-NAME. Endothelium-dependent contractions evoked by acetylcholine in the presence of L-NAME were reduced by Wy14643, fenofibrate but not rosiglitazone. Moreover, Wy14643 and fenofibrate inhibited acetylcholine-induced prostanoids release to the same extent. Our data suggests that the three PPAR activators induce nitric oxide-mediated relaxation through activation of AMPK. This relaxing effect is more prominent with Wy14643. Together with the ability to reduce the release of endothelium-dependent contracting factor, it appears that Wy14643 produces better protection against vascular diseases in spontaneous hypertension. | - |
dc.language | eng | en_HK |
dc.publisher | Federation of American Societies for Experimental Biology. The Journal's web site is located at http://www.fasebj.org/ | - |
dc.relation.ispartof | The FASEB Journal | - |
dc.subject | Biology | - |
dc.title | Beneficial vascular effect of a non-selective PPAR activator in aorta of spontaneously hypertensive rats | en_HK |
dc.type | Conference_Paper | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0892-6638&volume=24&issue=Meeting Abstracts, abstract no. 955.10&spage=&epage=&date=2010&atitle=Beneficial+vascular+effect+of+a+non-selective+PPAR+activator+in+aorta+of+spontaneously+hypertensive+rats | - |
dc.identifier.email | Leung, SWS: swsleung@HKUCC.hku.hk | en_HK |
dc.identifier.email | Vanhoutte, PM: vanhoutt@hku.hk | en_HK |
dc.identifier.email | Man, RYK: rykman@hkucc.hku.hk | en_HK |
dc.identifier.authority | Leung, SWS=rp00235 | en_HK |
dc.identifier.authority | Vanhoutte, PM=rp00238 | en_HK |
dc.identifier.authority | Man, RYK=rp00236 | en_HK |
dc.description.nature | link_to_OA_fulltext | - |
dc.identifier.hkuros | 172950 | en_HK |
dc.identifier.volume | 24 | - |
dc.identifier.issue | meeting abstracts | - |
dc.description.other | The ASIP Annual Meeting at Experimental Biology (EB 2010), Anaheim, CA., 24-28 April 2010. In The FASEB Journal, 2010, v. 24 meeting abstracts, abstract no. 955.10 | - |
dc.identifier.issnl | 0892-6638 | - |